Steroid Drugs Inhibit Bacterial Respiratory Oxidases and Are Lethal Toward Methicillin-Resistant Staphylococcus aureus.

IF 5 2区 医学 Q2 IMMUNOLOGY
Samantha A Henry, Calum M Webster, Lindsey N Shaw, Nathanial J Torres, Mary-Elizabeth Jobson, Brendan C Totzke, Jessica K Jackson, Jake E McGreig, Mark N Wass, Gary K Robinson, Mark Shepherd
{"title":"Steroid Drugs Inhibit Bacterial Respiratory Oxidases and Are Lethal Toward Methicillin-Resistant Staphylococcus aureus.","authors":"Samantha A Henry, Calum M Webster, Lindsey N Shaw, Nathanial J Torres, Mary-Elizabeth Jobson, Brendan C Totzke, Jessica K Jackson, Jake E McGreig, Mark N Wass, Gary K Robinson, Mark Shepherd","doi":"10.1093/infdis/jiad540","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Cytochrome bd complexes are respiratory oxidases found exclusively in prokaryotes that are important during infection for numerous bacterial pathogens.</p><p><strong>Methods: </strong>In silico docking was employed to screen approved drugs for their ability to bind to the quinol site of Escherichia coli cytochrome bd-I. Respiratory inhibition was assessed with oxygen electrodes using membranes isolated from E. coli and methicillin-resistant Staphylococcus aureus strains expressing single respiratory oxidases (ie, cytochromes bd, bo', or aa3). Growth/viability assays were used to measure bacteriostatic and bactericidal effects.</p><p><strong>Results: </strong>The steroid drugs ethinylestradiol and quinestrol inhibited E. coli bd-I activity with median inhibitory concentration (IC50) values of 47 ± 28.9 µg/mL (158 ± 97.2 µM) and 0.2 ± 0.04 µg/mL (0.5 ± 0.1 µM), respectively. Quinestrol inhibited growth of an E. coli \"bd-I only\" strain with an IC50 of 0.06 ± 0.02 µg/mL (0.2 ± 0.07 µM). Growth of an S. aureus \"bd only\" strain was inhibited by quinestrol with an IC50 of 2.2 ± 0.43 µg/mL (6.0 ± 1.2 µM). Quinestrol exhibited potent bactericidal effects against S. aureus but not E. coli.</p><p><strong>Conclusions: </strong>Quinestrol inhibits cytochrome bd in E. coli and S. aureus membranes and inhibits the growth of both species, yet is only bactericidal toward S. aureus.</p>","PeriodicalId":50179,"journal":{"name":"Journal of Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":5.0000,"publicationDate":"2024-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11272085/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/infdis/jiad540","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Cytochrome bd complexes are respiratory oxidases found exclusively in prokaryotes that are important during infection for numerous bacterial pathogens.

Methods: In silico docking was employed to screen approved drugs for their ability to bind to the quinol site of Escherichia coli cytochrome bd-I. Respiratory inhibition was assessed with oxygen electrodes using membranes isolated from E. coli and methicillin-resistant Staphylococcus aureus strains expressing single respiratory oxidases (ie, cytochromes bd, bo', or aa3). Growth/viability assays were used to measure bacteriostatic and bactericidal effects.

Results: The steroid drugs ethinylestradiol and quinestrol inhibited E. coli bd-I activity with median inhibitory concentration (IC50) values of 47 ± 28.9 µg/mL (158 ± 97.2 µM) and 0.2 ± 0.04 µg/mL (0.5 ± 0.1 µM), respectively. Quinestrol inhibited growth of an E. coli "bd-I only" strain with an IC50 of 0.06 ± 0.02 µg/mL (0.2 ± 0.07 µM). Growth of an S. aureus "bd only" strain was inhibited by quinestrol with an IC50 of 2.2 ± 0.43 µg/mL (6.0 ± 1.2 µM). Quinestrol exhibited potent bactericidal effects against S. aureus but not E. coli.

Conclusions: Quinestrol inhibits cytochrome bd in E. coli and S. aureus membranes and inhibits the growth of both species, yet is only bactericidal toward S. aureus.

类固醇药物可抑制细菌呼吸道氧化酶并对耐甲氧西林金黄色葡萄球菌具有杀伤力。
背景:细胞色素 bd 复合物是原核生物中独有的呼吸氧化酶,在许多细菌病原体的感染过程中起着重要作用:方法:采用默克对接法筛选已获批准的药物,以确定它们与大肠杆菌细胞色素 bd-I 的喹啉位点结合的能力。使用从表达单一呼吸氧化酶(即细胞色素 bd、bo'或 aa3)的大肠杆菌和耐甲氧西林金黄色葡萄球菌菌株中分离出来的膜,通过氧电极评估呼吸抑制作用。生长/存活率试验用于测量抑菌和杀菌效果:结果:类固醇药物炔雌醇和炔诺酮能抑制大肠杆菌 bd-I 的活性,中位抑制浓度(IC50)分别为 47 ± 28.9 µg/mL (158 ± 97.2 µM)和 0.2 ± 0.04 µg/mL (0.5 ± 0.1 µM)。喹乙醇抑制大肠杆菌 "bd-I only "菌株生长的 IC50 为 0.06 ± 0.02 µg/mL (0.2 ± 0.07 µM)。金黄色葡萄球菌 "仅限 bd "菌株的生长受到喹雌醇的抑制,IC50 为 2.2 ± 0.43 µg/mL (6.0 ± 1.2 µM)。喹雌醇对金黄色葡萄球菌有很强的杀菌作用,但对大肠杆菌没有作用:结论:喹乙醇能抑制大肠杆菌和金黄色葡萄球菌膜上的细胞色素 bd,并抑制这两种细菌的生长,但只对金黄色葡萄球菌有杀菌作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Infectious Diseases
Journal of Infectious Diseases 医学-传染病学
CiteScore
13.50
自引率
3.10%
发文量
449
审稿时长
2-4 weeks
期刊介绍: Published continuously since 1904, The Journal of Infectious Diseases (JID) is the premier global journal for original research on infectious diseases. The editors welcome Major Articles and Brief Reports describing research results on microbiology, immunology, epidemiology, and related disciplines, on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune responses. JID is an official publication of the Infectious Diseases Society of America.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信